Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group-Reference-Cited by-同舟云学术

Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group

Published:2022-12-15 Issue:2 Volume:12 Page:303-315
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

González-López Tomás José^ORCID,Bárez Abelardo,Bernardo-Gutiérrez Angel,Bernat Silvia,Canaro-Hirnyk Mariana,Entrena-Ureña Laura,Fernández-Fuertes Fernando,Guinea de Castro José María,Jiménez-Bárcenas Reyes,Pascual-Izquierdo Cristina,Sánchez-González Blanca,Jarque Isidro^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-022-00745-2.pdf

Reference44 articles.

1. Rahman A, Niloofa R, Jayarajah U, De Mel S, Abeysuriya V, Seneviratne SL. Hematological abnormalities in COVID-19: a narrative review. Am J Trop Med Hyg. 2021;104(4):1188–201.

2. Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020;95(6):E131–4.

3. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145–8.

4. Zhang Y, Zeng X, Jiao Y, Li Z, Liu Q, Ye J, et al. Mechanisms involved in the development of thrombocytopenia in patients with COVID-19. Thromb Res. 2020;193:110–5.

5. Alharbi MG, Alanazi N, Yousef A, Alanazi N, Alotaibi B, Aljurf M, et al. COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis. Expert Rev Hematol. 2022;15(2):157–66.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches;Cell Communication and Signaling;2024-02-15

2. Challenges in treating primary immune thrombocytopenia patients undergoing COVID-19 vaccination: A retrospective study;Open Medicine;2024-01-01

3. Changes in Adenosine Deaminase Activity and Endothelial Dysfunction after Mild Coronavirus Disease-2019;International Journal of Molecular Sciences;2023-08-24

4. Severe immune thrombocytopenia that developed immediately after COVID-19 in a school-aged patient: A case report;Frontiers in Pediatrics;2023-03-22

5. Association of SARS-CoV-2 viral load with abnormal laboratory characteristics and clinical outcomes in hospitalised COVID-19 patients;Epidemiology and Infection;2023